OR WAIT null SECS
Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.
Activation and expansion are essential for success in both autologous and allogeneic therapies.
Continuous manufacturing and a quality-by-design development approach are a natural fit.
January 30, 2023
This event is now available on-demand!
January 25, 2023
Webinar Date/Time: Tuesday, February 21st, 2023 at 11am EST | 8am PST | 4pm GMT | 5pm CET
January 18, 2023
Recently, 2seventy bio announced the initiation of a strategic partnership with JW Therapeutics aiming at the collaboration being the development of 2seventy bio’s MAGE-A4 cell therapy in mainland China, Hong Kong, and Macao.
January 12, 2023
Webinar Date/Time: Tue, Jan 31, 2023 11:00 AM EST
January 11, 2023
This self-emulsifying system improves the miscibility and dispersibility of formulations in aqueous environments and may improve API solubility.
January 10, 2023
Public relations agencies dissect pharmaceutical trends: Brandwidth Solutions, Orientation Marketing and White Matter Communications
January 04, 2023
Advancing the use of AI to understand the whole of a disease can reveal drug development insights that lead to drug discovery breakthroughs.
January 03, 2023
This compilation allows readers to adjust their thinking to appreciate the full impact certain select technologies will make on the industry by 2026.
Inhaled vaccines must resist degradation and penetrate the mucosal lining in the airways and lungs.
January 02, 2023
Cell and gene therapies is unequivocally viewed as the biggest opportunity in the bio/pharma space.